Latest DNA microarray Stories
Mapping DNase I hypersensitive sites has long been the standard method for identifying genetic regulatory elements such as promoters, enhancers, silencers, insulators, and locus control regions.
A new assay capable of examining hundreds of proteins at once and enabling new experiments that could dramatically change our understanding of cancer and other diseases has been invented by a team of University of Chicago scientists.
Genomic switches can predispose an individual to one set of autoimmune disorders but protect the same person against another set of them, scientists at Stanford University School of Medicine have found.
NEW YORK, Dec.
FREMONT, Calif., Nov. 19 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
POTOMAC FALLS, Va., Nov. 9 /PRNewswire/ -- TessAraeÂ® LLC, a global leader in resequencing microarray-based applications, announces the launch of new integrated product solutions for genetic testing of the mutations that underlie human hereditary diseases.
AMSTERDAM, October 29 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD).
A team of scientists, led by a biomedical engineer at The University of Texas at Austin, have demonstrated â€“ for the first time â€“ that mathematical models created from data obtained by DNA microarrays, can be used to correctly predict previously unknown cellular mechanisms.
CARLISLE, Mass., Aug. 5 /PRNewswire/ -- CapitalBio Corporation and VigeneTech Inc. have announced the launch of a fully integrated microarray solution platform.
For the first time, researchers have been able to identify genetic predictors of the potential success or failure of IVF treatment in blood.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.